Option Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Holocene Advisors LP

Holocene Advisors LP cut its position in Option Care Health, Inc. (NASDAQ:OPCH) by 20.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,906,723 shares of the company’s stock after selling 505,011 shares during the quarter. Holocene Advisors LP’s holdings in Option Care Health were worth $59,680,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of the company. FMR LLC grew its stake in shares of Option Care Health by 134.0% in the third quarter. FMR LLC now owns 7,516,448 shares of the company’s stock valued at $235,265,000 after buying an additional 4,304,896 shares in the last quarter. Westfield Capital Management Co. LP boosted its holdings in Option Care Health by 10.2% in the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock valued at $203,204,000 after purchasing an additional 599,589 shares during the period. Thrivent Financial for Lutherans boosted its holdings in Option Care Health by 7.4% in the third quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company’s stock valued at $183,541,000 after purchasing an additional 404,811 shares during the period. Dimensional Fund Advisors LP boosted its holdings in Option Care Health by 6.5% in the second quarter. Dimensional Fund Advisors LP now owns 3,605,271 shares of the company’s stock valued at $99,870,000 after purchasing an additional 218,844 shares during the period. Finally, Massachusetts Financial Services Co. MA boosted its holdings in Option Care Health by 2.6% in the third quarter. Massachusetts Financial Services Co. MA now owns 2,518,923 shares of the company’s stock valued at $78,842,000 after purchasing an additional 63,955 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. Truist Financial decreased their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a report on Friday, November 1st. Barrington Research decreased their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a report on Thursday, October 31st. JMP Securities lifted their price target on Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a report on Monday, September 30th. Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and decreased their price target for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. Finally, Bank of America downgraded Option Care Health from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $30.83.

Insider Activity

In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of Option Care Health stock in a transaction dated Friday, November 8th. The stock was acquired at an average cost of $22.54 per share, with a total value of $969,220.00. Following the acquisition, the director now owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.64% of the company’s stock.

Option Care Health Stock Up 1.3 %

Option Care Health stock opened at $24.12 on Tuesday. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $34.63. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The company has a market capitalization of $4.10 billion, a P/E ratio of 20.27, a PEG ratio of 2.46 and a beta of 1.33. The stock has a 50-day simple moving average of $26.84 and a 200-day simple moving average of $28.87.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.